Correlates of suicide and violence risk 1: the suicide risk measure.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 2758804)

Published in Compr Psychiatry on September 11, 1989

Authors

R Plutchik1, H M van Praag, H R Conte, S Picard

Author Affiliations

1: Albert Einstein College of Medicine, Bronx, NY.

Articles by these authors

Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb (1994) 2.47

High cholesterol levels in patients with panic disorder. Am J Psychiatry (1992) 2.25

Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res (1990) 1.59

Tomato exo-(1-->4)-beta-D-galactanase. Isolation, changes during ripening in normal and mutant tomato fruit, and characterization of a related cDNA clone. Plant Physiol (1995) 1.52

Induction of intrauterine growth restriction with a low-sodium diet fed to pregnant rats. Am J Obstet Gynecol (1999) 1.50

[Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. Ned Tijdschr Geneeskd (1997) 1.43

Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia (1993) 1.41

Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology (2002) 1.40

[Mania: clinical aspects, cause and treatment]. Ned Tijdschr Geneeskd (1994) 1.40

Transformation of arachidonic acid in leukocytes. Isolation and structural analysis of a novel dihydroxy derivative. Prostaglandins Med (1981) 1.36

Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin Pharmacol Ther (1974) 1.23

Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol (1971) 1.23

Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl) (1999) 1.22

Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study. Lancet (1978) 1.19

Is there a relation between the seriousness of suicidal intent and the lethality of the suicide attempt? Psychiatry Res (1989) 1.18

Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. J Clin Invest (1986) 1.17

Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun (2005) 1.12

Automated on-line extraction and profiling of lipoxygenase products of arachidonic acid by high-performance liquid chromatography. Methods Enzymol (1990) 1.10

Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4). Mol Pharmacol (1999) 1.07

Eosinophil-rich human polymorphonuclear leukocyte preparations characteristically release leukotriene C4 on ionophore A23187 challenge. J Allergy Clin Immunol (1984) 1.06

Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand (1981) 1.05

Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr Scand (1993) 1.05

Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils. J Immunol (1982) 1.05

A self-report measure of violence risk, II. Compr Psychiatry (1990) 1.04

Interconvertability of five self-report measures of depression. Psychiatry Res (1987) 1.04

Measuring death anxiety: conceptual, psychometric, and factor-analytic aspects. J Pers Soc Psychol (1982) 1.01

The role of serotonin in schizophrenia. Schizophr Bull (1988) 1.00

A self-report Borderline Scale. Discriminative validity and preliminary norms. J Nerv Ment Dis (1980) 1.00

Significance of cocaine history in schizophrenia. J Nerv Ment Dis (1990) 0.99

Cerebral monoamines and depression. An investigation with the Probenecid technique. Arch Gen Psychiatry (1973) 0.99

Suicidal behavior in latency-age children: an empirical study. J Am Acad Child Psychiatry (1979) 0.98

Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils. FASEB J (1998) 0.98

5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (1970) 0.98

Psychological mindedness as a predictor of psychotherapy outcome: a preliminary report. Compr Psychiatry (1990) 0.98

Management of depression with serotonin precursors. Biol Psychiatry (1981) 0.97

Pharmacological activity of leukotrienes A4, B4, C4 and D4 on selected guinea-pig, rat, rabbit and human smooth muscles. Prostaglandins Med (1981) 0.97

Correlates of suicide and violence risk: III. A two-stage model of countervailing forces. Psychiatry Res (1989) 0.96

Studies on the mechanism of formation of the 5S, 12S-dihydroxy-6,8,10,14(E,Z,E,Z)-icosatetraenoic acid in leukocytes. Prostaglandins (1982) 0.95

Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils. Am J Respir Crit Care Med (2000) 0.95

Depression. Lancet (1982) 0.94

Specificity of the effect of lipoxygenase metabolites of arachidonic acid on calcium homeostasis in neutrophils. Correlation with functional activity. J Biol Chem (1982) 0.94

Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res (1991) 0.92

Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry (1999) 0.91

Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. Arch Gen Psychiatry (1986) 0.91

Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils. J Exp Med (1997) 0.90

The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones. Neuropsychobiology (1984) 0.89

The role of serotonin in schizophrenia. Eur Neuropsychopharmacol (1995) 0.88

Retarded depression and the dopamine metabolism. Psychopharmacologia (1971) 0.88

Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy. Circ Res (1999) 0.88

Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils. Br J Pharmacol (2006) 0.88

Studies on leukotriene B4 omega-oxidation in human leukocytes. Can J Biochem Cell Biol (1984) 0.87

Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J Lipid Res (1998) 0.86

Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci (1995) 0.86

The therapeutic effect of short-term oral diazepam treatment on acute clinical anxiety in a crisis centre. Acta Psychiatr Scand (1974) 0.86

A controlled study of temporal lobe structure volumes and P300 responses in schizophrenic patients with persistent auditory hallucinations. Schizophr Res (1999) 0.86

Specificity of the tryptophan depletion method. Psychopharmacology (Berl) (1999) 0.86

Toward a rationale for the seclusion process. J Nerv Ment Dis (1978) 0.85

Serotonin and anxiety revisited. Biol Psychiatry (1988) 0.85

The role of the chief resident: expectations and reality. Am J Psychiatry (1976) 0.85

Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Int Clin Psychopharmacol (1996) 0.85

Neuroleptics as a guideline to biological research in psychotic disorders. Compr Psychiatry (1975) 0.85

Lipids, lipid-lowering therapy and diabetes complications. Diabetes Metab (2010) 0.84

Correlates of risk of suicide in violent and nonviolent psychiatric patients. Am J Psychiatry (1991) 0.84

Compliance with psychiatric emergency room referrals. Arch Gen Psychiatry (1977) 0.84

A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol Psychiatry (1971) 0.84

Kinetics of l-5-hydroxytryptophan in healthy subjects. Psychiatry Res (1982) 0.84

Central serotonin metabolism and frequency of depression. Psychiatry Res (1979) 0.84

Structural requirement for the action of leukotriene B4 on the guinea-pig lung:importance of double bond geometry in the 6, 8, 10-triene unit. Biochem Biophys Res Commun (1981) 0.83

Suicidal behavior in latency-age children. An outpatient population. J Am Acad Child Psychiatry (1980) 0.83

Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine. Psychiatry Res (1998) 0.82

Evidence for a mediator role of thromboxane A2 in the myotropic action of leukotriene B4 (LTB4) on the guinea-pig lung. Prostaglandins Leukot Med (1982) 0.82

The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiatr Neurol Neurochir (1966) 0.82

The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biol Psychiatry (1991) 0.82

19-Hydroxyprostaglandin B2 as an internal standard for on-line extraction-high-performance liquid chromatography analysis of lipoxygenase products. Anal Biochem (1988) 0.82

Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. Am J Psychiatry (1973) 0.82

Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. J Endocrinol (1998) 0.82

Central monoamine deficiency in depressions: causative of secondary phenomenon? Pharmakopsychiatr Neuropsychopharmakol (1975) 0.82

Suicidal behaviors in adult psychiatric outpatients, I: Description and prevalence. Am J Psychiatry (1993) 0.82

Intellectual disability and homelessness. J Intellect Disabil Res (2011) 0.82

Effects of different dietary ω-6/3 polyunsaturated fatty acids ratios on infarct size and the limbic system after myocardial infarction. Can J Physiol Pharmacol (2011) 0.82

Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. Int Clin Psychopharmacol (1995) 0.82

Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses. Circ Res (2001) 0.81

Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi alpha) in spontaneously hypertensive rats. Am J Hypertens (1991) 0.81

Double dioxygenation of arachidonic acid in leukocytes by lipoxygenases. Adv Prostaglandin Thromboxane Leukot Res (1982) 0.81

The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man. Psychopharmacologia (1973) 0.81

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology (Berl) (1988) 0.81

Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat. J Steroid Biochem Mol Biol (2000) 0.81

Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arterioscler Thromb Vasc Biol (1995) 0.81

Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res (1988) 0.80

The effect of stress on the dexamethasone suppression test. Psychiatry Res (1985) 0.80

Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry (1990) 0.80

Diabetes: statins, fibrates, or both? Curr Atheroscler Rep (2001) 0.80

Suicide and violence associated with panic attacks. Biol Psychiatry (1992) 0.80

Cyclic GMP inhibits a pharmacologically distinct Na+/H+ exchanger variant in cultured rat astrocytes via an extracellular site of action. J Neurochem (1997) 0.80

Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res (1998) 0.80

Effects of gestation on enzymes controlling aldosterone synthesis in the rat adrenal. Endocrinology (1997) 0.80

Effect of physiological concentrations of insulin and glucagon on the relationship between nonesterified fatty acids availability and ketone body production in humans. Metabolism (1991) 0.79